Condition
Progressive pulmonary fibrosis interstitial lung disease with evidence of eosinophilia
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by 07 Wv Sodium Carboxy Methyl Cellulose 10 Mm Acetate 250 Mmlproline 001 Wv Polysorbate 80 Ph 50
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Phase 2 (1)
Trial Status
Suspended1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- 07 Wv Sodium Carboxy Methyl Cellulose 10 Mm Acetate 250 Mmlproline 001 Wv Polysorbate 80 Ph 501
- Tezepelumab1
Active Sponsors
- Philipps-Universitaet Marburg1